Clinical Trial Update: Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease

View source ↗

Summary

The clinical trial investigating molecular mechanisms in systemic lupus erythematosus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Systemic Lupus Erythematosus | Status: WITHDRAWN